Inogen | INGN - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 6.8B 1.72B 2026-03
Accuray USD 41.29M 22.05M 2025-12
AngioDynamics USD 41.64M 14.26M 2025-09
Artivion USD 77.32M 21.55M 2026-06
AtriCure USD 167.79M 21.62M 2026-06
Baxter International USD 2.15B 133M 2026-06
Becton, Dickinson and Co. USD 708M 105M 2026-06
Boston Scientific USD 539M 914M 2026-06
Cooper Companies USD 138.8M 13.9M 2026-03
Dexcom USD 1.1B 13.2M 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
Globus Medical USD 507.74M 53.2M 2026-06
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 534.9M 54.5M 2026-06
Medtronic USD 1.69B 258M 2026-06
Orthofix International USD 103.81M 16.47M 2026-06
Philips EUR 1.79B 803M 2026-06
ResMed USD 1.47B 191.28M 2026-06
Steris USD 482.3M 42.7M 2026-06
Stryker USD 3.39B 513M 2026-06
Tandem Diabetes Care USD 62.82M 116.51M 2026-06
Teleflex USD 300.16M 9.25M 2026-06
X T L Biopharmaceuticals USD 76K 295K 2025-12
Zimmer Biomet Holdings USD 410M 14.2M 2026-06